Thomas C Chen sold $956K of NeOnc Technologies (NTHI)

Executed Mar 26 2025, disclosed Apr 8 2025, 13 days later, against a two-business-day limit.

Value, as filed

$956K

38,250 sh × $25.00

Executed

Mar 26 2025

the trade date, as filed

Disclosed

Apr 8 2025

13 days after the trade · past the deadline

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

Thomas C Chen Chief Scientific Officer profile →

Thomas C Chen (Chief Scientific Officer) filed 2 Form 4 reports in the trailing twelve months (2 purchases, 0 sales, 1 filed past the two-business-day deadline), most often in NeOnc Technologies Holdings, Inc. (NTHI). Across 1 priced purchase filing, the average 21-session return was +17.4% from execution and -38.6% from disclosure (delay-adjusted; derived). The largest single filing was $130K of NTHI (33,787 sh × $3.85, as filed), executed Aug 14.

The name

NTHI

NeOnc Technologies Holdings, Inc. NTHI · Healthcare · 16 filings in 24 months ticker →

Healthcare · NeOnc Technologies Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on developing treatments for intracranial malignanci…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Thomas C Chen in NTHI

NTHIPURCHASE NeOnc Technologies Holdings, Inc. $130K
33,787 sh × $3.85
Exec Aug 14
Filed Aug 20 · 9:15 PM ET † NTHIPURCHASE NeOnc Technologies Holdings, Inc. $130K
33,787 sh × $3.85
Exec Aug 14
Filed Aug 18 · 4:13 PM ET NTHISALE NeOnc Technologies Holdings, Inc. $956K
38,250 sh × $25.00
Exec Mar 26 2025
Filed Jun 5 2025 · 5:30 PM ET †